1) Concurrent chemoradiotherapy
同时化放疗
2) Concurrent chemoradiotherapy
同时放化疗
1.
This article discussed the establishment of concurrent chemoradiotherapy,the possible biological interaction mechanisms and clinical practice.
综合治疗是治疗肿瘤的基本原则,同时放化疗已成为肿瘤临床治疗中最常见的综合治疗形式。
2.
Objective: To investigate the proteomic differences between thehigh-sensitivity (HS) group and the low-sensitivity(LS) group of cervicalcarcinoma treated by concurrent chemoradiotherapy and confirm theconcurent chemoradiotherapy sensitivity associated proteins in interme-diate stage and advanced cervical carcinoma.
目的：采用双向凝胶电泳(two-dimensional gel electrophoresis，2-DE)结合MALDI-TOF-MS质谱分析技术比较同时放化疗高敏感和低敏感中晚期宫颈癌组织之间蛋白质组的差异，识别和鉴定高敏感组和低敏感组之间差异表达的蛋白质，初步确定中晚期宫颈癌同时放化疗敏感性相关的蛋白质，为中晚期宫颈癌患者同时放化疗敏感性的预测提供理论依据。
3) Concurrent chemoradiotherapy
同期放化疗
1.
PhaseⅠ and Ⅱ Clinical Trial of Concurrent Chemoradiotherapy of Cisplatin with 5-Fluorouracil and Its Short-Term Effect on Quality of Life of Concurrent Chemoradiotherapy in Chinese Patients with Esophageal Cancer;
食管癌PF方案同期放化疗的Ⅰ期和Ⅱ期临床试验及其对食管癌患者近期生存质量影响的临床研究
2.
Near effects of concurrent chemoradiotherapy for quality of life on non-small-cell lung cancer patients
同期放化疗对晚期非小细胞肺癌患者近期生活质量的影响
3.
A randomized clinical control study on weekly concurrent chemoradiotherapy with oxaliplatin or cisplatin in the treatment of loco-regional advanced nasopharyngeal carcinoma
每周奥沙利铂或顺铂同期放化疗治疗局部晚期鼻咽癌的随机对照研究
5) chemoradiotherapy
同步放化疗
1.
Curative effect of preoperative chemoradiotherapy and radiotherapy for the patients with bulky cervical cancer in early stage;
早期巨块型宫颈癌术前同步放化疗与单纯放疗的近期疗效对比分析
2.
Changes of HPV DNA and TNF-α levels in patients with advanced cervical cancer before and after concurrent chemoradiotherapy;
宫颈癌同步放化疗前后HPV DNA及TNF-α的变化
3.
Value of EGFR and HER2 to predict the sensitivity of chemoradiotherapy in the esophageal squamous cell carcinoma
EGFR,HER2预测食管鳞状细胞癌同步放化疗敏感性的价值
6) Concurrent radiochemotherapy
同步放化疗
1.
Phase Ⅰ trial of postoperative concurrent radiochemotherapy for patients with Ⅰ_(b1)-Ⅱ_b cervical carcinoma;
Ⅰ_(b1)-Ⅱ_b期宫颈癌术后同步放化疗的Ⅰ期临床研究
2.
Standardization of concurrent radiochemotherapy in locally advanced NSCLC
局部晚期非小细胞肺癌同步放化疗规范
3.
Objective To evaluate the effects of megestrol acetate (MA) in protecting marrow, decreasing digestive tract reaction and improving the quality of life in the patients with nasopharyngeal carcinoma(NPC) at stage Ⅱ～Ⅲ treated with concurrent radiochemotherapy.
目的评价甲地孕酮在Ⅱ~Ⅲ期鼻咽癌患者同步放化疗中保护骨髓、减少消化道反应以及改善患者生活质量的作用。
补充资料：公理化方法(见公理化和形式化)
公理化方法(见公理化和形式化)
axiomatical method
gongllbuafangfa公理化方法化和形式化。(axiomatieal method)见公理
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条